Results from University of Glasgow studies show association between fecal albumin levels and parasitism, before and after anthelmintic treatment.
Aurora, OH (June 12, 2014) – A scientific poster derived from research trials involving the SUCCEED Equine Fecal Blood Test was presented at the American College of Veterinary Internal Medicine Forum, June 4-7, 2014, in Nashville, TN. “The effect of parasite burden on faecally excreted albumin in horses” was presented by the principal researcher, Nicola Kerbyson, BVMS, Cert AVP (EM), MRCVS, a PhD student at the University of Glasgow (Scotland).
The aim of the study was to establish if albumin excreted in a horse’s feces, measured using the SUCCEED Equine Fecal Blood Test, was related to the parasite burden of the horse. The results indicate that parasite burden is associated with the likelihood of being positive for fecal albumin using the SUCCEED fecal occult blood test kit. The 21 horses in the study were administered moxidectin for seasonal treatment of encysted cyathstomes, and those horses with an ELISA optical density of greater than 0.2 (indicating a high level of tapeworm infection intensity) were also administered praziquantel. Among the study horses, 81 percent produced a positive result for fecal albumin prior to anthelmintic treatment. SUCCEED FBT results showed 29 percent positive for fecal albumin following treatment. This difference was found to be statistically significant (P= 0.001).
The study presented is one of six clinical research trials utilizing the SUCCEED Equine Fecal Blood Test currently in progress, five at the University of Glasgow (Scotland) and the sixth in Ireland. The trials are being conducted under the supervision of Derek Knottenbelt, OBE, BVM&S, DipECEIM, MRCVS, and Tim Parkin, PhD, DipECVPH, MRCVS. Knottenbelt is Professor of Equine Medicine at the University of Liverpool (UK) and Clinical Consultant at the Weipers Centre Equine Hospital at the University of Glasgow. Parkin is Senior Research Fellow with the School of Veterinary Medicine, University of Glasgow.
Results of these various trials will be presented at a number of different scientific conferences worldwide throughout 2014. This includes:
- Oral and poster presentations at the Equine Colic Research Symposium hosted by the British Equine Veterinary Association (BEVA) in Dublin, Ireland, July 8-10.
- Presentations at the first annual Evidence-Based Veterinary Medicine Network (EBVM) Conference in Windsor, UK, October 23-24.
- Oral presentation at the AAEP Convention in Salt Lake City in December. Multiple abstracts have also been submitted to the ECEIM Congress (European College of Equine Internal Medicine) in Prague, Czech Republic, November 6-8.
The SUCCEED Equine Fecal Blood Test (FBT) is an equine-specific fecal blood test that aids the veterinarian’s diagnosis of digestive tract conditions in equine patients. For more information, visit www.succeedFBT.com.
The SUCCEED FBT is produced by Freedom Health LLC of Aurora, Ohio. The company is focused on finding, perfecting and delivering superior, innovative products that address real and significant health-related issues for animals and the people who care for them.